Division of Rheumatology, Department of Internal Medicine, School of Medicine, Eskişehir Osmangazi University, Eskişehir, 26480, Turkey.
Department of Pathology, Eskişehir Osmangazi University, Eskişehir, Turkey.
Rheumatol Int. 2021 Oct;41(10):1845-1853. doi: 10.1007/s00296-021-04822-6. Epub 2021 Mar 9.
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.
类风湿关节炎(RA)是一种慢性自身免疫性疾病,其特征为关节和关节外表现。在关节外表现中,类风湿性脑膜炎(RM)是一种罕见的疾病,其可能表现出多变的症状,包括头痛、局灶性和/或全身性神经功能缺损。它可能作为 RA 的前期表现出现,也可能在疾病过程中的任何时间发生。一些用于治疗 RA 的药物可能由于其免疫抑制作用而引起无菌性脑膜炎或增加感染性脑膜炎的倾向。所有这些可能性都可能导致鉴别诊断困难。在短时间内做出诊断对预后至关重要。在这里,我们想报告一例长期 RA 患者,在开始依那西普(ETA)治疗后不久出现左侧无力和癫痫。适当的诊断工具证实了 ETA 引起的脑膜炎。我们希望通过这个基于病例的回顾,引起对这种罕见疾病的关注,并讨论诊断方面的挑战。